Stage 4 Cytokine Release Syndrome Caused by the First Dose of Nivolumab and Ipilimumab Combination Therapy in a Patient with Metastatic Melanoma Successfully Treated with Methylprednisolone, Tocilizumab, and Etanercept

The authors report the first case of stage 4 cytokine release syndrome (CRS) (graded by the National Cancer Institute Common Terminology Criteria for Adverse Effects scale) involving a patient with advanced metastatic melanoma who was treated with the combination of two monoclonal antibodies, nivolu...

Descripción completa

Detalles Bibliográficos
Autores principales: Menakuru, Sasmith R., Azeem, Qiraat, Priscu, Adelina, Khan, Ibrahim, Beirat, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294929/
https://www.ncbi.nlm.nih.gov/pubmed/35949898
http://dx.doi.org/10.1159/000525173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294929/
https://www.ncbi.nlm.nih.gov/pubmed/35949898
http://dx.doi.org/10.1159/000525173

Ejemplares similares